Extracorporeal liver support and liver transplantation for acute‐on‐chronic liver failure

体外 医学 肝移植 重症监护医学 失代偿 移植 临床试验 生命维持 肝衰竭 肝肾综合征 生物人工肝装置 内科学 肝硬化 肝细胞 体外 化学 生物化学
作者
María Pilar Ballester,Ahmed El Shabrawi,Rajiv Jalan
出处
期刊:Liver International [Wiley]
卷期号:45 (3): e15647-e15647 被引量:19
标识
DOI:10.1111/liv.15647
摘要

Acute-on-chronic liver failure (ACLF) is defined by acute decompensation, organ failure and a high risk of short-term mortality. This condition is characterized by an overwhelming systemic inflammatory response. Despite treating the precipitating event, intensive monitoring and organ support, clinical deterioration can occur with very poor outcomes. During the last decades, several extracorporeal liver support systems have been developed to try to reduce ongoing liver injury and provide an improved environment for the liver to regenerate or as a bridging therapy until liver transplantation. Several clinical trials have been performed to evaluate the clinical efficacy of extracorporeal liver support systems, but no clear impact on survival has been proven. DIALIVE is a novel extracorporeal liver support device that has been built to specifically address the pathophysiological derangements responsible for the development of ACLF by replacing dysfunctional albumin and removing pathogen and damage-associated molecular patterns (PAMPs and DAMPs). In phase II clinical trial, DIALIVE appears to be safe, and it seems to be associated with a faster time to the resolution of ACLF compared with standard medical treatment. Even in patients with severe ACLF, liver transplantation saves lives and there is clear evidence of transplant benefit. Careful selection of patients is required to attain good results from liver transplantation, but many questions remain unanswered. In this review, we describe the current perspectives on the use of extracorporeal liver support and liver transplantation for ACLF patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
红红完成签到,获得积分10
1秒前
大雪纷飞发布了新的文献求助10
1秒前
Maestro_S的应助被果果采纳,获得10
1秒前
1秒前
stone发布了新的文献求助10
2秒前
2秒前
赘婿的应助被meng采纳,获得10
2秒前
aaa关闭了aaa的文献求助
2秒前
2秒前
HUSH994发布了新的文献求助30
3秒前
勤恳兔子的应助被小带采纳,获得10
3秒前
3秒前
情怀的应助被张延涛采纳,获得10
4秒前
4秒前
4秒前
lgs完成签到,获得积分10
5秒前
SciGPT的应助被Desperate采纳,获得10
5秒前
6秒前
王哲完成签到,获得积分10
6秒前
7秒前
7秒前
天天快乐的应助被w_w采纳,获得10
8秒前
8秒前
爆米花的应助被stitch采纳,获得10
9秒前
xyt071365发布了新的文献求助10
9秒前
123发布了新的文献求助10
9秒前
9秒前
bertharen完成签到,获得积分20
9秒前
HUSH994完成签到,获得积分10
9秒前
怡然缘分发布了新的文献求助10
9秒前
烟花的应助被既白采纳,获得10
10秒前
紫罗兰完成签到,获得积分10
10秒前
汉堡包的应助被MayorWang采纳,获得30
10秒前
天真从彤完成签到,获得积分10
10秒前
Cristol发布了新的文献求助10
10秒前
orixero的应助被look采纳,获得10
11秒前
11秒前
谢谢大佬发布了新的文献求助10
12秒前
范范范发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178203
求助须知:如何正确求助?哪些是违规求助? 9568998
关于积分的说明 21802098
捐赠科研通 7773088
什么是DOI,文献DOI怎么找? 3432711
关于科研通互助平台的介绍 2556748
邀请新用户注册赠送积分活动 2478259